Chemours Income Before Tax vs Depreciation And Amortization Analysis
CC Stock | USD 21.82 0.10 0.46% |
Chemours financial indicator trend analysis is way more than just evaluating Chemours prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Chemours is a good investment. Please check the relationship between Chemours Income Before Tax and its Depreciation And Amortization accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemours Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
Income Before Tax vs Depreciation And Amortization
Income Before Tax vs Depreciation And Amortization Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Chemours Income Before Tax account and Depreciation And Amortization. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Chemours' Income Before Tax and Depreciation And Amortization is -0.49. Overlapping area represents the amount of variation of Income Before Tax that can explain the historical movement of Depreciation And Amortization in the same time period over historical financial statements of Chemours Co, assuming nothing else is changed. The correlation between historical values of Chemours' Income Before Tax and Depreciation And Amortization is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Income Before Tax of Chemours Co are associated (or correlated) with its Depreciation And Amortization. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Depreciation And Amortization has no effect on the direction of Income Before Tax i.e., Chemours' Income Before Tax and Depreciation And Amortization go up and down completely randomly.
Correlation Coefficient | -0.49 |
Relationship Direction | Negative |
Relationship Strength | Very Weak |
Income Before Tax
Income Before Tax which can also be referred as pre-tax income is reported on Chemours income statement and is an important metric when analyzing Chemours profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.Depreciation And Amortization
The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.Most indicators from Chemours' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Chemours current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemours Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. At present, Chemours' Enterprise Value Multiple is projected to increase significantly based on the last few years of reporting.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 1.4B | 1.6B | 1.3B | 1.2B | Total Revenue | 6.3B | 6.8B | 6.0B | 5.1B |
Chemours fundamental ratios Correlations
Click cells to compare fundamentals
Chemours Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Chemours fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Common Stock Shares Outstanding | 164.8M | 166.3M | 168.7M | 158.3M | 148.9M | 140.1M | |
Total Assets | 7.3B | 7.1B | 7.6B | 7.6B | 8.3B | 7.5B | |
Other Current Liab | 477M | 449M | 545M | 475M | 1.2B | 1.3B | |
Total Current Liabilities | 1.5B | 1.4B | 1.9B | 1.9B | 2.5B | 1.8B | |
Total Stockholder Equity | 689M | 813M | 1.1B | 1.1B | 737M | 1.1B | |
Other Liab | 751M | 626M | 707M | 854M | 982.1M | 711.9M | |
Property Plant And Equipment Net | 3.9B | 3.7B | 3.4B | 3.4B | 3.5B | 3.6B | |
Accounts Payable | 923M | 820M | 1.2B | 1.2B | 1.1B | 1.1B | |
Non Current Assets Total | 4.5B | 4.4B | 4.2B | 4.4B | 4.4B | 4.4B | |
Non Currrent Assets Other | 391M | 252M | 310M | 573M | 374M | 416.1M | |
Other Assets | 292M | 405M | 547M | 725M | 833.8M | 424.1M | |
Long Term Debt | 4.0B | 4.0B | 3.7B | 3.6B | 4.0B | 3.2B | |
Net Receivables | 674M | 511M | 720M | 626M | 610M | 602.4M | |
Liabilities And Stockholders Equity | 7.3B | 7.1B | 7.6B | 7.6B | 8.3B | 7.5B | |
Non Current Liabilities Total | 5.0B | 4.8B | 4.6B | 4.6B | 5.0B | 4.1B | |
Inventory | 1.1B | 939M | 1.1B | 1.4B | 1.4B | 1.2B | |
Other Current Assets | 81M | 156M | 150M | 82M | 670M | 703.5M | |
Other Stockholder Equity | (213M) | (182M) | (303M) | (722M) | (773M) | (734.4M) | |
Total Liab | 6.6B | 6.3B | 6.5B | 6.5B | 7.5B | 6.0B | |
Property Plant And Equipment Gross | 3.9B | 3.7B | 9.2B | 9.4B | 9.6B | 5.2B | |
Total Current Assets | 2.8B | 2.6B | 3.3B | 3.2B | 3.8B | 3.0B | |
Accumulated Other Comprehensive Income | (349M) | (310M) | (364M) | (343M) | (274M) | (287.7M) | |
Short Term Debt | 134M | 78M | 84M | 141M | 106M | 97.8M | |
Intangible Assets | 28M | 21M | 14M | 6M | 3M | 2.9M | |
Property Plant Equipment | 3.9B | 3.5B | 3.4B | 3.2B | 3.6B | 3.5B | |
Net Tangible Assets | 515M | 646M | 973M | 992M | 892.8M | 710.5M | |
Retained Earnings | 1.2B | 1.3B | 1.7B | 2.2B | 1.8B | 1.1B | |
Cash | 943M | 1.1B | 1.5B | 1.1B | 1.2B | 1.1B | |
Deferred Long Term Liab | 148M | 36M | 49M | 61M | 54.9M | 96.1M | |
Long Term Investments | 162M | 167M | 169M | 175M | 158M | 171.6M | |
Short Long Term Debt | 13M | 134M | 21M | 25M | 51M | 41.5M | |
Short Long Term Debt Total | 4.4B | 4.3B | 3.9B | 3.8B | 4.3B | 4.4B | |
Net Debt | 3.5B | 3.2B | 2.5B | 2.7B | 3.1B | 2.4B | |
Cash And Short Term Investments | 943M | 1.1B | 1.5B | 1.1B | 1.2B | 1.2B | |
Retained Earnings Total Equity | 1.2B | 1.3B | 1.7B | 2.2B | 2.5B | 2.6B | |
Long Term Debt Total | 4.0B | 4.0B | 3.7B | 3.6B | 3.2B | 3.1B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemours Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Is Diversified Chemicals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemours. If investors know Chemours will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemours listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.65) | Dividend Share 1 | Earnings Share 0.5 | Revenue Per Share 38.519 | Quarterly Revenue Growth 0.009 |
The market value of Chemours is measured differently than its book value, which is the value of Chemours that is recorded on the company's balance sheet. Investors also form their own opinion of Chemours' value that differs from its market value or its book value, called intrinsic value, which is Chemours' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemours' market value can be influenced by many factors that don't directly affect Chemours' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemours' value and its price as these two are different measures arrived at by different means. Investors typically determine if Chemours is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemours' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.